New drug cocktail tested in global fight against spreading bowel cancer

NCT ID NCT06820463

Summary

This study is testing whether adding an experimental drug called telisotuzumab adizutecan to standard chemotherapy works better for people with metastatic colorectal cancer. About 390 adults worldwide will receive different combinations of these drugs to find the safest and most effective dose. The main goals are to see if the treatment shrinks tumors and to monitor side effects over approximately six years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aichi Cancer Center /ID# 270113

    RECRUITING

    Nagoya, Aichi-ken, 464-8681, Japan

  • Austin Health /ID# 270692

    RECRUITING

    Heidelberg, Victoria, 3084, Australia

  • Centre Hospitalier Universitaire de Poitiers /ID# 270225

    RECRUITING

    Poitiers, Nouvelle-Aquitaine, 86021, France

  • Chu De Lille - Hopital Claude Huriez /ID# 270222

    RECRUITING

    Lille, Hauts-de-France, 59037, France

  • City of Hope National Medical Center /ID# 270255

    RECRUITING

    Duarte, California, 91010, United States

  • Dana-Farber Cancer Institute /ID# 270624

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Fakultni Thomayerova nemocnice /ID# 269632

    RECRUITING

    Prague, Praha, Hlavni Mesto, 140 59, Czechia

  • Fakultní nemocnice Hradec Králové - Sokolská /ID# 268773

    RECRUITING

    Hradec Králové, Hradec Kralove, 500 05, Czechia

  • Hadassah Medical Center-Hebrew University /ID# 268007

    RECRUITING

    Jerusalem, 91120, Israel

  • Hope And Healing Cancer Services /ID# 271562

    RECRUITING

    Hinsdale, Illinois, 60521, United States

  • Hospital Universitario Marques de Valdecilla /ID# 269732

    RECRUITING

    Santander, Cantabria, 39008, Spain

  • Hospital Universitario Vall de Hebron /ID# 270191

    RECRUITING

    Barcelona, 08035, Spain

  • Hôpital Européen Georges Pompidou /ID# 270224

    RECRUITING

    Paris, 75015, France

  • Kaohsiung Chang Gung Memorial Hospital /ID# 269726

    RECRUITING

    Kaohsiung City, Kaohsiung, 833, Taiwan

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 269724

    RECRUITING

    Kaohsiung City, 807, Taiwan

  • Linkou Chang Gung Memorial Hospital /ID# 269725

    RECRUITING

    Taoyuan, 333, Taiwan

  • Macquarie University /ID# 271514

    RECRUITING

    Sydney, New South Wales, 2109, Australia

  • Mater Hospital Brisbane /ID# 270694

    RECRUITING

    South Brisbane, Queensland, 4101, Australia

    Contact Phone: •••-•••-••••

  • Medizinische Universitaet Wien /ID# 268872

    RECRUITING

    Vienna, 1090, Austria

  • National Cancer Center Hospital /ID# 270112

    RECRUITING

    Chuo-Ku, Tokyo, 104-0045, Japan

  • National Cancer Center Hospital East /ID# 270114

    RECRUITING

    Kashiwa-shi, Chiba, 277-8577, Japan

  • National Cheng Kung University Hospital /ID# 270835

    RECRUITING

    Tainan, 704, Taiwan

  • National Taiwan University Hospital /ID# 269717

    RECRUITING

    Taipei, 100, Taiwan

  • Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646

    RECRUITING

    Omaha, Nebraska, 68130, United States

  • Oncology Hematology Care - Eastgate /ID# 271493

    RECRUITING

    Cincinnati, Ohio, 45245, United States

  • One Clinical Research /ID# 270695

    RECRUITING

    Nedlands, Western Australia, 6009, Australia

  • Pan American Center for Oncology Trials /ID# 268809

    RECRUITING

    Rio Piedras, 00935, Puerto Rico

  • Rabin Medical Center. /ID# 268008

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Rambam Health Care Campus- Haifa /ID# 268006

    RECRUITING

    Haifa, 3525408, Israel

  • Saint Lukes Hospital of Kansas City /ID# 270633

    RECRUITING

    Kansas City, Missouri, 64111, United States

  • Shaare Zedek Medical Center /ID# 268009

    RECRUITING

    Jerusalem, 9103102, Israel

  • St Marianna University School Of Medicine /ID# 270111

    RECRUITING

    Kawasaki-shi, Kanagawa, 216-8511, Japan

  • St. Luke's Hospital S.A. /ID# 269963

    RECRUITING

    Panórama, Thessaloniki, 55236, Greece

  • Taipei Veterans General Hospital /ID# 269718

    RECRUITING

    Taipei, 112, Taiwan

  • Tel Aviv Sourasky Medical Center /ID# 268010

    RECRUITING

    Tel Aviv, Tel Aviv, 6423906, Israel

  • Texas Oncology - Austin Midtown /ID# 271354

    RECRUITING

    Austin, Texas, 78705, United States

  • Texas Oncology - Deke Slayton Cancer Center /ID# 271355

    RECRUITING

    Webster, Texas, 77598, United States

  • The Queen Elizabeth Hospital /ID# 270693

    RECRUITING

    Woodville, South Australia, 5011, Australia

  • Theagenio Cancer Hospital /ID# 269640

    RECRUITING

    Thessaloniki, 54639, Greece

  • Tohoku University Hospital /ID# 270966

    RECRUITING

    Sendai, Miyagi, 980-8574, Japan

  • University of North Carolina Medical Center /ID# 267786

    RECRUITING

    Chapel Hill, North Carolina, 27514, United States

  • Yale New Haven Hospital /ID# 270565

    RECRUITING

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.